autoimmune disease testing
Anne E. Tebo, PhD, acting assistant medical director of the Immunology Laboratory, addresses co-morbidity, lab methodology, and genetic markers related to autoimmune disease testing. Dr. Tebo believes the lab will play an ever-increasing role in autoantibody profiling for individuals with autoimmune diseases. As our understanding of autoimmune diseases improves, so too will their diagnosis, monitoring, and treatment.
- Autoimmune thyroid diseases, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and celiac disease are the most prevalent autoimmune disorders in the United States. Lab testing for these conditions is well established, but diagnostic paradigms and focus are shifting, as some clinical and laboratory evidence shows that certain autoimmune diseases are often co-morbid with others. See more
(Advance for Administrators of the Laboratory. “Autoimmune Diseases: Moving Toward a Genetic Approach.” November 2007.)